Matt Schappell
Investor at Frist Cressey Ventures
Nashville, Tennessee
Matt Schappell, Investor at Frist Cressey Ventures is an active investor based in Nashville, Tennessee. This profile covers what Matt Schappell backs, at which stage, and how founders can reach out in 2026.
- Investor type
- VCMicro VCPE
- Stages
- SeedSeries ASeries BLate Stage Venture
- Invests in
- Digital Health & HealthTechHealthcare & BiotechSaaS & Enterprise
- Location
- Nashville, Tennessee
- Typical check
- $2M
- Past investments
- 12
Notable investments
InformedDNA
Audacious Inquiry
Monogram HealthStratasan
180 Health Partners
Regroup Therapy
Ready
Klara
Relode
Aspire Health
DexCareValifyHow to reach Matt Schappell
Angels and operators like Matt Schappell reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded Accelerator.
Connect with Matt Schappell
Frequently Asked Questions
What does Matt Schappell invest in?
Matt Schappell invests in Digital Health & HealthTech, Healthcare & Biotech and SaaS & Enterprise, typically at Seed, Series A, Series B and Late Stage Venture. Match your sector and stage, then reach out with a personalized pitch.
What stage does Matt Schappell invest at?
Matt Schappell typically invests at Seed, Series A, Series B and Late Stage Venture. Lead with traction that fits the stage when you reach out.
What is Matt Schappell's typical check size?
Matt Schappell typically writes checks around $2M. Use it as a signal for whether your raise fits their stage.
How do I contact Matt Schappell?
Unlock Matt Schappell's verified email on Round Funded Accelerator and send a personalized pitch. We surface only deliverable contacts so your outreach lands.